Published in J Immunol on May 01, 1979
Subpopulations of circulating B cells and regulatory T cells involved in in vitro immunoglobulin E production in atopic patients with elevted serum immunoglobulin E. J Clin Invest (1980) 1.68
Deficiency of suppressor T cells in the hyperimmunoglobulin E syndrome. J Clin Invest (1981) 1.63
Differential requirements of B cells from normal and allergic subjects for the induction of IgE synthesis by an alloreactive T cell clone. J Exp Med (1985) 1.35
In vitro production of IgE by human peripheral blood mononuclear cells. I. Rate of IgE biosynthesis. Clin Exp Immunol (1980) 1.34
Recent studies on the regulation of IgE antibody synthesis in experimental animals and man. Immunology (1980) 1.28
In vitro production of IgE by human peripheral blood mononuclear cells. II. Cells involved in the spontaneous IgE production in atopic patients. Clin Exp Immunol (1980) 1.19
In vitro stimulation of IgE production at a single precursor level by human alloreactive T helper clones. Clin Exp Immunol (1984) 1.11
In vitro synthesis of IgE by human peripheral blood leucocytes. III. Release of pre-formed antibody. Clin Exp Immunol (1983) 1.09
In vitro synthesis of IgE by human peripheral blood leucocytes. II modulation of IgE B cell activity by isotype-specific regulatory T cells. Clin Exp Immunol (1981) 1.07
Stimulation of primary in vitro IgE antibody responses in culture of human peripheral mononuclear cells. J Exp Med (1981) 1.02
IgE synthesis in vitro induced by T cell factors from patients with elevated serum IgE levels. Clin Exp Immunol (1983) 0.99
In vitro synthesis of IgE by human lymphocytes. I. The spontaneous secretion of IgE by B lymphocytes from allergic individuals: a model to investigate the regulation of human IgE synthesis. Immunology (1984) 0.99
In vitro production of IgE by human peripheral blood mononuclear cells. III. Demonstration of a circulating IgE-bearing cell involved in the spontaneous IgE biosynthesis. Clin Exp Immunol (1982) 0.97
In vitro synthesis of IgE by human peripheral blood leucocytes: relationship to serum titre of leucocyte donor. Clin Exp Immunol (1981) 0.96
Regulation of human immunoglobulin E synthesis in acute graft versus host disease. J Clin Invest (1983) 0.88
In vitro production of IgE by human peripheral blood mononuclear cells. IV. Modulation by allergen of the spontaneous IgE antibody biosynthesis. Clin Exp Immunol (1982) 0.87
Regulation of immunoglobulin E antibody synthesis in man by antiidiotypic antibodies. J Clin Invest (1983) 0.86
Selective enhancement of human IgE production in vitro by synergy of pokeweed mitogen and mercuric chloride. Clin Exp Immunol (1983) 0.83
IgE production in vitro by peripheral blood mononuclear cells of patients with parasitic helminth infections. Clin Exp Immunol (1984) 0.82
Antigen-induced inhibition of human in vitro spontaneous IgE synthesis. I. Factors and kinetic studies. Clin Exp Immunol (1985) 0.77
Role of T gamma cells in the in vitro IgE response after antigenic stimulation. Clin Exp Immunol (1981) 0.75
Human rib bone marrow mononuclear cells spontaneously synthesize and secrete IgE in vitro. Clin Exp Immunol (1991) 0.75
Suppression of IgE synthesis in vitro by allogeneic T cells from atopic and non-atopic subjects. Clin Exp Immunol (1985) 0.75
Comparison of IgE expression at the mRNA and protein levels in vitro. Immunology (1991) 0.75
Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med (1996) 5.69
The eosinophilic leukocyte: structure and function. Adv Immunol (1986) 4.08
Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res (1988) 3.47
Measurement of IgE in normal and allergic serum by radioimmunoassay. J Lab Clin Med (1971) 3.47
Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis (1988) 3.45
Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev (1992) 3.42
Cytotoxic properties of the eosinophil major basic protein. J Immunol (1979) 3.29
An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med (1990) 3.05
Sudden-onset fatal asthma. A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa? Am Rev Respir Dis (1993) 2.83
Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol (1979) 2.81
Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest (1980) 2.70
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome? Mayo Clin Proc (1992) 2.64
Pulmonary epithelial cell expression of GM-CSF corrects the alveolar proteinosis in GM-CSF-deficient mice. J Clin Invest (1996) 2.49
The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol (1986) 2.29
Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet (1982) 2.21
The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies. J Clin Invest (1976) 2.19
Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis (1989) 2.08
The clinical spectrum of the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion. Clinical features in 20 patients and aspects of pathophysiology. Ann Intern Med (1990) 2.06
Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N Engl J Med (1990) 2.05
Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet (1987) 1.98
Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest (1976) 1.96
Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med (1998) 1.90
The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci U S A (1999) 1.90
Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med (1973) 1.87
Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci U S A (1981) 1.85
Elevated levels of the eosinophil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc (1981) 1.85
Molecular cloning of the human eosinophil peroxidase. Evidence for the existence of a peroxidase multigene family. J Exp Med (1989) 1.83
IgA-induced eosinophil degranulation. J Immunol (1989) 1.82
Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan. N Engl J Med (1990) 1.80
Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis. N Engl J Med (1985) 1.79
Eosinophilic myocarditis manifesting as myocardial infarction: early diagnosis and successful treatment. Mayo Clin Proc (1997) 1.78
Granulocyte/macrophage colony-stimulating factor and interleukin 3 release from human peripheral blood eosinophils and neutrophils. J Exp Med (1991) 1.77
Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury. Am J Respir Cell Mol Biol (1999) 1.75
Eosinophils 1992. Immunol Today (1992) 1.69
Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med (1983) 1.69
Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc Natl Acad Sci U S A (1986) 1.67
Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J Immunol (1986) 1.65
Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J Immunol (1989) 1.64
Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects. Am Rev Respir Dis (1987) 1.62
Physiochemical and biological properties of the major basic protein from guinea pig eosinophil granules. J Exp Med (1974) 1.61
Selective stimulation and purification of eosinophils and neutrophils from guinea pig peritoneal fluids. J Lab Clin Med (1973) 1.61
Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol (1991) 1.60
Human eosinophil major basic protein induces airway constriction and airway hyperresponsiveness in primates. J Clin Invest (1991) 1.60
Eosinophil infiltration and degranulation in normal human tissue. Anat Rec (1998) 1.59
Interferon-alpha treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med (1994) 1.58
Tissue eosinophilia and eosinophil degranulation in syndromes associated with fibrosis. Am J Pathol (1992) 1.58
Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology (1999) 1.54
Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg (1994) 1.54
Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor. J Clin Invest (1993) 1.53
The late phase of the immunoglobulin E-mediated reaction: a link between anaphylaxis and common allergic disease? J Allergy Clin Immunol (1982) 1.53
Nodules, eosinophilia, rheumatism, dermatitis and swelling (NERDS): a novel eosinophilic disorder. Clin Exp Allergy (1993) 1.52
Human eosinophil major basic protein causes hyperreactivity of respiratory smooth muscle. Role of the epithelium. Am Rev Respir Dis (1988) 1.52
Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol (1997) 1.52
Antibody formation in dysgammaglobulinemia. J Clin Invest (1966) 1.50
Serum IgE in dermatitis and dermatosis: an analysis of 497 cases. Arch Dermatol (1977) 1.48
Induced sputum: validity of fluid-phase IL-5 measurement. J Allergy Clin Immunol (2000) 1.47
Elevated serum levels of the eosinophil granule major basic protein in patients with eosinophilia. J Clin Invest (1981) 1.46
Regulatory effect of cytokines on eosinophil degranulation. J Immunol (1990) 1.45
Ablation of immunity to Amblyomma americanum by anti-basophil serum: cooperation between basophils and eosinophils in expression of immunity to ectoparasites (ticks) in guinea pigs. J Immunol (1982) 1.45
Eosinophil cationic granule proteins impair thrombomodulin function. A potential mechanism for thromboembolism in hypereosinophilic heart disease. J Clin Invest (1993) 1.45
Response of six patients with idiopathic hypereosinophilic syndrome to interferon alfa. J Allergy Clin Immunol (1994) 1.44
Anaphylactic transfusion reactions associated with anti-IgA antibody. N Engl J Med (1969) 1.44
Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol (1983) 1.43
Allelic heterogeneity in hereditary surfactant protein B (SP-B) deficiency. Am J Respir Crit Care Med (2000) 1.42
Removal of bronchoalveolar cells augments the late eosinophilic response to segmental allergen challenge. Clin Exp Allergy (2002) 1.41
Eosinophilic endomyocardial disease presenting as cyanosis, platypnea, and orthodeoxia. Ann Intern Med (1992) 1.41
Extensive eosinophil degranulation and peroxidase-mediated oxidation of airway proteins do not occur in a mouse ovalbumin-challenge model of pulmonary inflammation. J Immunol (2001) 1.40
The role of eosinophils in the pathogenesis of asthma. Curr Opin Immunol (1994) 1.38
Episodic angioedema associated with eosinophilia. N Engl J Med (1984) 1.38
Surfactant protein deficiency in familial interstitial lung disease. J Pediatr (2001) 1.37
Damage to Trichinella spiralis newborn larvae by eosinophil major basic protein. Am J Trop Med Hyg (1979) 1.37
Localization of eosinophil granule major basic protein in chronic urticaria. J Invest Dermatol (1983) 1.36
Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol (1984) 1.35
Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum Gene Ther (1995) 1.35
Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence. J Exp Med (1979) 1.34
Immunoglobulin E (IgE) levels in serum and synovial fluid in rheumatoid arthritis. Arthritis Rheum (1975) 1.34
Pretreatment with antibody to eosinophil major basic protein prevents hyperresponsiveness by protecting neuronal M2 muscarinic receptors in antigen-challenged guinea pigs. J Clin Invest (1997) 1.33
Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma. Am Rev Respir Dis (1985) 1.32
Formation of Charcot-Leyden crystals by human basophils. J Exp Med (1982) 1.30
Low molecular weight IgM in human sera. J Lab Clin Med (1969) 1.30
Comparative toxicity of purified human eosinophil granule cationic proteins for schistosomula of Schistosoma mansoni. Am J Trop Med Hyg (1985) 1.29
Penicillin allergy: clinical experience with a battery of skin-test reagents. J Allergy Clin Immunol (1982) 1.29
Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol (1991) 1.29
Activation of platelets by eosinophil granule proteins. J Exp Med (1990) 1.29
Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity. J Biol Chem (1992) 1.27
Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood (1985) 1.27
Strongyloides stercoralis: eosinophil-dependent immune-mediated killing of third stage larvae in BALB/cByJ mice. Exp Parasitol (1996) 1.27
An immunofluorescent method for specific staining of eosinophil granule major basic protein. J Immunol Methods (1981) 1.26
In vitro killing of microfilariae of Brugia pahangi and Brugia malayi by eosinophil granule proteins. J Immunol (1990) 1.25
Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein. J Biol Chem (1988) 1.25
Eosinophil granule proteins in peripheral blood granulocytes. J Leukoc Biol (1992) 1.24
Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab Invest (1986) 1.24
Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med (1984) 1.22
Ontogeny of surfactant proteins A and B in human amniotic fluid as indices of fetal lung maturity. Pediatr Res (1991) 1.22
Eosinophil cationic protein cDNA. Comparison with other toxic cationic proteins and ribonucleases. J Immunol (1989) 1.21
Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci (1991) 1.19
Two highly homologous ribonuclease genes expressed in mouse eosinophils identify a larger subgroup of the mammalian ribonuclease superfamily. Proc Natl Acad Sci U S A (1996) 1.19
Comparative toxicity of purified human eosinophil granule proteins for newborn larvae of Trichinella spiralis. J Parasitol (1987) 1.18
Destruction of bloodstream forms of Trypanosoma cruzi by eosinophil granule major basic protein. Am J Trop Med Hyg (1981) 1.17